83 related articles for article (PubMed ID: 2117333)
1. [Clinical pharmacologic study of Tri-Regol tablets (new oral triphase contraceptives)].
Farkas M; Kovács L; Tasiné Tóth E
Acta Pharm Hung; 1990 May; 60(2-3):85-99. PubMed ID: 2117333
[TBL] [Abstract][Full Text] [Related]
2. [The effect of oral ovulation inhibiting (mono-, bi- and triphase) contraceptives and of Continuin and Postinor on proteo- and steroid hormones].
Farkas M
Acta Pharm Hung; 1992; 62(1-2):17-30. PubMed ID: 1566635
[TBL] [Abstract][Full Text] [Related]
3. Clinicopharmacological examination of Anteovin.
Farkas M; Szigethy A; Sas M
Ther Hung; 1987; 35(1):14-8. PubMed ID: 3438859
[TBL] [Abstract][Full Text] [Related]
4. Change to Tri-Regol from other oral contraceptives.
Garamvölgyi G
Ther Hung; 1991; 39(3):122-4. PubMed ID: 1818425
[TBL] [Abstract][Full Text] [Related]
5. Observations with a tri-phasic oral contraceptive (Tri-Regol) in everyday clinical practice.
Kovács I; Novák K; Pomázi L; Hammersberg E
Ther Hung; 1992; 40(2):86-9. PubMed ID: 1462283
[TBL] [Abstract][Full Text] [Related]
6. Action of hormonal contraceptives on the coagulation system and some of its inhibitors.
Misz M; Beck P
Acta Med Hung; 1986; 43(3):301-10. PubMed ID: 2438639
[TBL] [Abstract][Full Text] [Related]
7. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
Schneider WH; Schmid R; Spona J
Wien Klin Wochenschr; 1981 Oct; 93(19):601-4. PubMed ID: 6798765
[TBL] [Abstract][Full Text] [Related]
8. Contraception and therapy with Tri Regol tablet.
Adám J
Ther Hung; 1991; 39(2):75-7. PubMed ID: 1948781
[TBL] [Abstract][Full Text] [Related]
9. The relationship between vascular headaches and low-dose oral contraceptives.
Karsay K
Ther Hung; 1990; 38(4):181-5. PubMed ID: 2094059
[TBL] [Abstract][Full Text] [Related]
10. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
Palatsi R; Reinilä M; Kivinén S
Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
[TBL] [Abstract][Full Text] [Related]
11. How rapid is the return of fertility after the use of Tri-Regol oral contraceptive?
Adám J
Ther Hung; 1992; 40(1):16-9. PubMed ID: 1585278
[TBL] [Abstract][Full Text] [Related]
12. [Clinico-laboratory research on the pharmacodynamic characteristics of Rigevidon].
Korkhov VV; Nikanorova SA
Farmakol Toksikol; 1987; 50(1):97-100. PubMed ID: 3556564
[TBL] [Abstract][Full Text] [Related]
13. Observations with a combined oral contraceptive (Rigevidon) containing minimum oestrogen dose.
Karsay K
Ther Hung; 1980; 28(1):17-20. PubMed ID: 7281074
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
[TBL] [Abstract][Full Text] [Related]
15. [Hypophyseal reaction state during oral contraceptiva (author's transl)].
Gitsch E; Schneider WH; Schmid R; Spona J
Wien Klin Wochenschr; 1981 Oct; 93(19):599-601. PubMed ID: 6798764
[TBL] [Abstract][Full Text] [Related]
16. [Practical observations of the use of the contraceptive preparation Anteovin].
Milchev N; Pekhlivanov B; Piperkov T
Akush Ginekol (Sofiia); 1990; 29(6):88-90. PubMed ID: 2100964
[TBL] [Abstract][Full Text] [Related]
17. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
[TBL] [Abstract][Full Text] [Related]
18. [The clinico-pharmacological characteristics of anteovin].
Nikanorova SA; Kononova ES; Korkhov VV; Potin VV; Svechnikova FA; Boĭkova VV
Farmakol Toksikol; 1991; 54(1):30-1. PubMed ID: 1860494
[TBL] [Abstract][Full Text] [Related]
19. [Tri-Regol and its application in gynecological practice].
Marinov B; Kolarov G
Akush Ginekol (Sofiia); 2000; 39(3):56-7. PubMed ID: 11188001
[TBL] [Abstract][Full Text] [Related]
20. Use of triphasic Tri-Regol tablet in women of borderline age.
Takács G
Ther Hung; 1991; 39(4):188-91. PubMed ID: 1811332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
